New identity

Posted on 18 December 2020 by FSCCF

The Swiss Foundation against Liver Cancer is getting a new look with a new identity and a new website.

Liver cancer: improving screening to save lives.Event

FondationCancerFoieFollow

Retweet on Twitter FondationCancerFoie Retweeted

Dufour @dufour_jf·

24 Mar

'NASH limits anti-tumour surveillance in immunotherapy-treated HCC' & 'Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH' 2 landmark papers http://go.nature.com/2Po4T9F & http://go.nature.com/3cjahDZ @CancerInflam @LorenzaRimassa @jaumebosch9 @DrLoomba @QAnstee

Reply on Twitter 1374821867928834054 Retweet on Twitter 137482186792883405417 Like on Twitter 137482186792883405446 Twitter 1374821867928834054

Retweet on Twitter FondationCancerFoie Retweeted

Dufour @dufour_jf·

20 Mar

HCC recurrence after DAA therapy: an individual patient data meta-analysis. A large collaboration led by @ma5RN @cabibbo78 in @Gut_BMJ @emadelomar http://bit.ly/2PbmQrA

Reply on Twitter 1373197643455868930 Retweet on Twitter 137319764345586893018 Like on Twitter 137319764345586893041 Twitter 1373197643455868930

Retweet on Twitter FondationCancerFoie Retweeted

Keith Siau @drkeithsiau·

30 Jan

Beta-blockers in cirrhosis - check out this phenomenal review by @jaumebosch9 #livertwitter #MedEd

https://www.jhep-reports.eu/article/S2589-5559(19)30157-0/fulltext

Reply on Twitter 1355638626714083333 Retweet on Twitter 1355638626714083333184 Like on Twitter 1355638626714083333515 Twitter 1355638626714083333

Enter your email address to stay in touch with the Foundation